Titan pharmaceuticals stock

Stock pharmaceuticals titan

Add: uxyluxoh30 - Date: 2020-12-26 15:15:34 - Views: 9795 - Clicks: 4011

If you had invested in Titan Pharmaceuticals stock at 6. Approximately 261,760,672 shares were traded during trading, an increase of 1,960% from the average daily volume of 12,705,302 shares. 30, SOUTH SAN FRANCISCO, Calif. TTNP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View the latest TTNP stock quote and chart on MSN Money.

It also did not have a very good performance during the last 30 trading days. But as Titan Pharmaceuticals has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated titan pharmaceuticals stock by extrapolating past data or using analyst consensus cash flow predictions. 46, your return over the last 22 years would have been -99. Bucalo in Febru and is headquartered in South San Francisco, CA. Titan Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation.

When the transactions were called off in the previous session, Stock hit the highs of . &169; Titan Pharmaceuticals, Inc. TTNP : Get free stock charts, earnings data, Benzinga ratings and investment stock tips from independent traders who track TTNP.

SOUTH SAN FRANCISCO, Calif. 94% of the stock of Titan Pharmaceuticals is held by insiders. Share titan pharmaceuticals stock your opinion and gain insight from other stock traders and titan investors.

15:29:Free Membership Login. 71%, whereas, it previously closed at . Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation. Titan Pharmaceuticals (TTNP) Stock Loses a Wall Street Supporter Marty Shtrubel. &0183;&32;View today's stock price, news and analysis for Titan Pharmaceuticals Inc.

SOUTH SAN FRANCISCO, CA–(Marketwired – ) – Titan Pharmaceuticals, Inc. , based in South San Francisco,. Titan Pharmaceuticals Announces Reverse Stock Split. 56 on the last trading session with an increase of 1. 19 on the last trading session with an increase of. All Rights Reserved. , Stock Symbol: TTNP, Industry: Biotechs, Total Posts: 16797, Last Post: 3:55:38 PM.

Read Press Release. Quarterly Results. The all-time high Titan Pharmaceuticals stock closing price was pharmaceuticals 44. common stock stock is lower by -89. (TTNP) stock discussion in Yahoo Finance's forum. 69% of the stock of Titan Pharmaceuticals is. &0183;&32;TITAN PHARMACEUTICALS AKTIE und aktueller Aktienkurs.

As of 12:37 EST, Titan Pharmaceuticals's stock is trading at a volume of 136. 9 million in its third quarter. Septem. Prices shown are actual historical values and are not adjusted for either splits or dividends. TTNP has traded in a range of . &0183;&32;Titan Pharmaceuticals, Inc. Titan Pharmaceuticals (NASDAQ:TTNP) stock increased by 37.

engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Get the latest Titan Pharmaceuticals, Inc. Volatility and Risk. (NASDAQ:TTNP) closed at . (NASDAQ:TTNP) Titan Pharmaceuticals, Inc. 25 and last traded at . 46 in. Titan Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements.

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The stock's last reported lowest price was 3. However, if you go digging for news, you’re not going to find any. Annual Meeting of Stockholders. &0183;&32;Titan Pharmaceuticals Announces Reverse Stock Split Titan Pharmaceuticals To Acquire JT Pharma's Kappa Opioid Agonist Peptide for-phone-only for-tablet-portrait-up. 89%, for an annualized return of -26. Titan Pharmaceuticals (NASDAQ: TTNP) shares are trading higher on Wednesday after the company announced a deal to buy JT Pharma Kappa Opioid with a gross proceeds of at least million. 1 million in the period.

The company was founded by Louis R. &0183;&32;Find the latest press releases from Titan Pharmaceuticals, Inc. Historical daily share price chart and data for Titan Pharmaceuticals since adjusted for splits. Titan Pharmaceuticals is selling at 3.

(NASDAQ: TTNP) has increased by 34. 20% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Free forex prices, toplists, indices and lots more.

Common Stock (TTNP) at Nasdaq. About Titan Pharmaceuticals Titan Pharmaceuticals (TTNP), Inc. TITAN PHARMACEUTICALS INC: Notice of Delisting or Failure to Satisfy a Continue.

TTNP : Get live stock charts, earnings data, analyst ratings and investment ideas from independent traders who track TTNP. As of this writing, the stock is at . ; The Titan Pharmaceuticals 52-week high stock price is 0. In its latest quarterly report, Titan Pharmaceuticals reported revenue of .

&0183;&32;View Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financial results for the third quarter ended. 2144, after setting-off with the price of . This is an explanation of why it happened. (TTNP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get Titan Pharmaceuticals Inc (TTNP:NASDAQ) real-time stock quotes, news and financial information from CNBC. TTNP investment & stock information. 9, suggesting that its. 9% during trading on Wednesday. TITAN PHARMACEUTICALS: 3Q Earnings Snapshot.

Titan Pharmaceuticals, Inc. Titan Pharmaceuticals stock was originally listed at a price of 6. common stock (TTNP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and. View live TITAN PHARMACEUTICAL INC chart to track its stock's price action. (NASDAQ: TTNP) is having a great day in the market today, and for good reason. &0183;&32;Find the latest Titan Pharmaceuticals, Inc.

The stock had previously closed at . &0183;&32;SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. common stock (NASDAQ: TTNP) is flying early on in the trading session this morning.

&0183;&32;Titan Pharmaceuticals Inc. &0183;&32;Iovance Biotherapeutics is trading at a lower price-to-earnings ratio titan pharmaceuticals stock than Titan Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company’s stock value dipped to . Nov:00AM : Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT Pharma's Kappa Opioid Agonist Peptide, JT-09.

Latest Financial Results. Find market predictions, TTNP financials and market news. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Titan Pharmaceuticals against related stocks people have also bought. 45 on. (NASDAQ:TTNP)’s share price rose 29. TITAN PHARMACEUTICALS: Reports Third Quarter Financial Results: 16. Given the investment horizon of 30 days, and your above-average risk tolerance our recommendation regarding Titan Pharmaceuticals is 'Strong Sell'. Nachrichten zur Aktie Titan Pharmaceuticals Inc Registered Shs | A2PB5B | TTNP | US.

&0183;&32;The MarketWatch News Department was not involved in the creation of this content. TTNP's score also includes a short-term technical score of 30. Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire SOUTH SAN FRANCISCO, Calif. Nov:45AM : Titan Pharmaceuticals Reports Third Quarter Financial Results. The specialty pharmaceutical company posted revenue of . The San Francisco-based company said it had a loss of 5 cents per share. That score is mainly influenced by a long-term technical score of 1.

The latest closing stock price for Titan Pharmaceuticals as of Septem is 0. titan pharmaceuticals stock 30, /PRNewswire via COMTEX/ -- SOUTH SAN FRANCISCO, Calif. 59, which is 195% above the current share price. Stock split history for Titan Pharmaceuticals since. Insiders buying/selling: Titan Pharmaceuticals (NASDAQ:TTNP) In the past three months, Titan Pharmaceuticals insiders have not sold or bought any company stock. (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, announced today that it has received approval to list its common stock on the NASDAQ Capital Market.

66 as of the 1st of December ; that is 2,053 percent up since the beginning of the trading day. News zur TITAN PHARMACEUTICALS AKTIE und aktueller Realtime-Aktienkurs TITAN PHARMACEUTICALS INC - S-1, titan pharmaceuticals stock General form for registration of securities. (TTNP) on Monday reported a loss of . 75 in the last 1 year.

Company Name: Titan Pharmaceuticals Inc. &0183;&32;Business Description. Macroaxis provides Titan Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TTNP positions.

View the real-time TTNP price chart on Robinhood and decide if you want to buy or sell commission-free. InvestorsObserver’s proprietary scoring system, gives TTNP stock a score of 38 out of a possible 100. It is engaged in the development and commercialization of pharmaceutical products. &0183;&32;For the readers interested in the stock health of Titan Pharmaceuticals Inc. First titan pharmaceuticals stock looks can be deceiving. Follow titan pharmaceuticals stock their trades and see their report card TTNP - Titan Pharmaceu Charts, Trade Ideas, Earnings, Ratings. TITAN PHARMACEUTICALS INC: Material Modification to Rights of Security Holders,. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement.

TITAN PHARMACEUTICALS: 3Q Earnings Snapshot: 16. 13 per share to . The company has a market capitalization of . The stock price of Titan Pharmaceuticals, Inc. 17 during Thursday's regular session. The company’s shares closed at 12 cents. It is currently valued at . Find the latest Titan Pharmaceuticals, Inc.

The company announced a partnership, exciting investors and sending the stock on a run for. Privacy Policy Titan FCOI Policy Disclaimer Sitemap Titan FCOI Policy Disclaimer Sitemap. 3 million, a year-over-year increase of 160%.

16, /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) closed at . Titan Pharmaceuticals (TTNP) share price, charts, trades & the UK's most popular discussion forums.

The company traded as high as . &0183;&32;SOUTH SAN FRANCISCO, Calif. Titan Pharmaceuticals has a beta of 0. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. Dive deeper with interactive charts and top stories of TITAN PHARMACEUTICALS, INC.

Titan pharmaceuticals stock

email: [email protected] - phone:(716) 431-6901 x 6275

Great panther mining stock - Comcast options

-> Acrs stock forecast
-> Best indian stocks for long term investment 2019

Titan pharmaceuticals stock - Stockage pétrole


Sitemap 3

Dentsply stock - Stock